BiotechTube
Home/Mesoblast/Dr. Silviu Itescu
DS

Dr. Silviu Itescu

Founder, Chief Executive Officer, and Executive Director

Mesoblast

Therapeutic Areas

Inflammatory DiseasesImmunologyCardiologyPain ManagementHematology/Oncology

Mesoblast Pipeline

DrugIndicationPhase
Rexlemestrocel-L (REVASCOR®)Advanced Chronic Heart Failure with Left Ventricular Assist Device (LVAD)Phase 3
Rexlemestrocel-LChronic Low Back Pain due to Degenerative Disc DiseasePhase 3
Remestemcel-L (RYONCIL®)Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD) in childrenPhase 3
Remestemcel-LAcute Respiratory Distress Syndrome (ARDS)Phase 2/3
MPC-06-IDInflammatory Bowel Disease (Crohn's Fistula)Phase 2
MPC-300-IVBiologic-Refractory Rheumatoid ArthritisPhase 2

Leadership Team at Mesoblast

JM
Josh Muntner
Chief Financial Officer
DF
Dr. Fred Grossman
Chief Medical Officer
DD
Dr. Donna Skerrett
Chief Executive Officer, Mesoblast Inc. (USA)
ER
Eric Rose, M.D.
Chairman of the Board
DA
Dr. Andrew J. Perlman
Independent Non-Executive Director
DE
Dr. Elizabeth (Liz) G. Nabel
Independent Non-Executive Director
DB
Dr. Bassem I. Razzouk
Independent Non-Executive Director
DJ
Dr. Julie G. Parsonnet
Independent Non-Executive Director
DA
Dr. Adrian (Adi) G. K. (Koh)
Independent Non-Executive Director
DJ
Dr. John J. L. (Lynch)
Independent Non-Executive Director
View full Mesoblast profile